| Institution: | 1. Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy;3. Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA;4. Harvard Medical School, Boston, USA;5. Department of Pathology, Brigham and Women''s Hospital, Boston, USA;6. Breast and Gynecologic Cancer Research, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, USA;7. Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, USA;8. University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA |
